Wave Life Sciences, Inc.

WVE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
ARS Oct 14, 2026 ARS
DEF 14A Oct 14, 2026 DEF 14A
4 Oct 7, 2026
4 Oct 7, 2026 4
4 Oct 7, 2026 4
4 Oct 7, 2026 4
4 Oct 7, 2026 4
4 Oct 7, 2026 4
4 Oct 7, 2026 4
4 Oct 7, 2026 4
EFFECT Aug 14, 2026
4 Aug 13, 2026 4
4 Aug 13, 2026 4
4 Aug 13, 2026 4
4 Aug 13, 2026 4
144 Aug 12, 2026
SCHEDULE 13D/A Aug 11, 2026
144 Aug 11, 2026
15-12G Aug 10, 2026 15-12G
POS AM Aug 10, 2026 POS AM
POSASR Aug 10, 2026 POSASR
S-8 POS Aug 10, 2026 S-8 POS
S-8 POS Aug 10, 2026 S-8 POS
S-8 POS Aug 10, 2026 S-8 POS
S-8 POS Aug 10, 2026 S-8 POS
← Newer Page 1 of 30 · 739 filings Older →